Anthem shareholders approve corporate rebranding to Elevance Health
The Indianapolis-based insurance giant said the new name will better reflect its mission of “elevating whole health and advancing health beyond health care.”
John Russell
Articles
UPDATE: IU Health doctor says he was fired for objecting to visit time limit
Dr. Brian Leon filed a lawsuit this month against Indiana University Health Care Associates Inc., alleging breach of contract, unpaid wages, fraudulent misrepresentation and numerous other claims.
FDA approves Lilly diabetes drug that helps patients lose weight
The drug has been closely watched by medical professionals and is viewed by financial analysts as a possible blockbuster, with potential annual sales in the billions of dollars.
Elanco reports solid quarter but global concerns lead to drop in share price
Several analysts said Elanco faces a bright future, implying that the market might be overreacting to the lowered revenue and profit guidance.
Lilly’s new weight-loss drug is a ‘double wow’ and likely blockbuster
The pharmaceutical giant is turning heads with an experimental medicine it claims can help obese patients shed nearly a quarter of their body weight and manage diabetes.
Ascension St. Vincent to build small hospital near Purdue
The Indianapolis-based health system said the new hospital will bring inpatient and emergency care into the city of West Lafayette for the first time.
Indiana ranked seventh in nation for hospital charge disparities
A new study released Thursday by the Rand Corp. showed that Hoosiers covered by employer health plans paid Indiana hospitals nearly three times—or 292%—of what Medicare would have paid for the same procedures.
Pandemic continued to financially punish Indiana hospitals in 1st quarter
Indiana University Health lost $29.8 million, and Community Health lost $28.5 million during the quarter, as both systems postponed surgeries to deal with the rising number of COVID-19 cases.
Life sciences experts say Indiana needs to push collaborations to compete with other states
A panel of Indiana life science experts on Friday said the state could become more competitive for large investments and jobs if it doubled down on the kind of collaborations and partnerships that other states have used to their advantage.
Lilly CEO has leaders talking about whether state is doing enough to grow Indiana
David Ricks’ lunchtime speech to The Economic Club of Indiana—repeated on social media by those in attendance and reported by IBJ and local TV stations—has reverberated across the state.
Community Health starts ‘fully integrated cancer program’ with MD Anderson
Community Health Network said the new arrangement with the largest cancer center in the United States will give Hoosiers access to some of the most advanced cancer treatments in the nation.
Lilly profit soars 40% in first quarter
Eli Lilly and Co. posted profit of $1.9 billion in the first quarter, up 40%, on higher sales of COVID-19 antibodies and other key products for diabetes, cancer and arthritis.
Lilly says experimental drug helped patients lose up to 22% of body weight
The drug, called tirzepatide, has been closely watched by medical professionals and is viewed by financial analysts as possible blockbuster, with potential annual sales in the billions of dollars.
Purdue, Duke Energy to study nuclear reactor to power campus
Just two months after Indiana lawmakers passed a law that would allow electric utilities to build small, prefabricated nuclear reactors, Purdue University and Duke Energy Corp. jointly announced Wednesday they plan to explore the feasibility of using the technology.
Indiana life sciences companies landed $15B in funding in 2021
The funding included 39 Indiana life-science companies raising $433.5 million last year in venture capital, an increase of almost $200 million compared to 2020, according to a report issued by BioCrossroads.
Indianapolis-based Telix rolls out method for detecting cancer
The imaging agent is the six-year-old company’s first commercial launch, following millions of dollars’ worth of research and clinical tests. It was approved by the U.S. Food and Drug Administration in December.
Lilly CEO: Indiana must improve education, reduce health care costs to stay competitive
When it comes to competing for jobs, Indiana is far behind the curve in critical ways, Eli Lilly and Co. CEO David Ricks told a lunch crowd Wednesday at the Economic Club of Indiana.
IU School of Medicine gets $12.5M gift commitment from Vera Bradley Foundation
The medical school said the commitment will help launch research efforts to develop better therapies for triple negative breast cancer, an aggressive form of breast cancer that is often not responsive to hormone therapies and is resistant to chemotherapy.
Indy-based Acacia Pharma being acquired by New Jersey firm; fate of local operations unknown
Acacia Pharma Group employees are waiting to see what will happen to their jobs and whether the company will remain in Indianapolis in any form, now that it is being acquired by New Jersey-based specialty drugmaker Eagle Pharmaceuticals Inc. for $103.9 million.
Q&A with Cathy Ferree, CEO of the Indiana State Museum
Ferree, who started her career as a security guard at The Children’s Museum of Indianapolis, now oversees a staff of about 150 and an annual budget of $12 million at the state museum and the state’s historic sites.